Skip to main content
Improved outcomes with IC/HMA+TKI combination therapy vs TKI alone in CML-MBP
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Improved outcomes with IC/HMA+TKI combination therapy vs TKI alone in CML-MBP
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Myelogenous Leukemia
1
1
Tyrosine Kinase Inhibitor
0
0.91
Leukemia
0
0.76
Biologic Therapy
0
0.6
Antineoplastic Drug
0
0.38
Tyrosine Kinase
0
0.38
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
1
Pharmacist
0
0.6